DTCFF News and Press, Defence Therapeutics Inc Cl A From 09/07/21

Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on ADC therapeutics for cancer targeting with its Accum TM technology and cancer vaccine ther...

Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a biotechnology company working on ADC therapeutics for cancer targeting with its Accum TM technology and cancer vaccine therap...

Vancouver, British Columbia--(Newsfile Corp. - August 18, 2021) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), is pleased to announce, that after a detailed and rigorous selection process, very strong and promising results of its bests Accum TM variants has been iden...